25/01/2011 Vall d'Hebron patents and sells a test that improves breast cancer treatment 25/01/2011 Vall d'Hebron researchers led by Dr. Joaquin Arribas have created a test to improve the treatment of breast cancer, have patented it and sold the license to the multinational pharmaceutical company GlaxoSmithKline to make it available to patients anywhere in the world. The discovery of this group of researchers from Vall d'Hebron Institute of Oncology (VHIO) is an example of how quality research can improve the lives of people and create economic wealth for the society as a whole. Another example of the transfer of knowledge to society is the responsible of the biomedical research and translational and pediatric oncology unit at Vall d'Hebron Research Institute (VHIR), Dr. Jaume Reventós, who founded the company TransBioMed and has recently developed innovative findings, as a test to detect prostate cancer. Vall d'Hebron researchers led by Dr. Joaquin Arribas have created a test to improve the treatment of breast cancer, have patented it and sold the license to the multinational pharmaceutical company GlaxoSmithKline to make it available to patients anywhere in the world. The discovery of this group of researchers from Vall d'Hebron Institute of Oncology (VHIO) is an example of how quality research can improve the lives of people and create economic wealth for the society as a whole. Another example of the transfer of knowledge to society is the responsible of the biomedical research and translational and pediatric oncology unit at Vall d'Hebron Research Institute (VHIR), Dr. Jaume Reventós, who founded the company TransBioMed and has recently developed innovative findings, as a test to detect prostate cancer. Twitter LinkedIn Facebook Whatsapp
